Drugs / Debio 4126
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05364944 | May 2022 → Oct 2024 | acromegaly, digestive system neuroendocrine neoplasm | Debiopharm International SA | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Debio 4126 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05364944 ↗ |